BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2025.
World J Psychiatry. Oct 19, 2025; 15(10): 110968
Published online Oct 19, 2025. doi: 10.5498/wjp.v15.i10.110968
Table 2 Exposure and dose modification (full analysis set), mean ± SD

Lurasidone (40 mg/day), n = 99
Lurasidone (80 mg/day), n = 98
Overall, n = 197
Exposure days on drug (day)38.6 ± 9.1632.7 ± 14.5535.7 ± 12.46
Total exposure level (mg)2436.4 ± 803.892492.0 ± 1147.472464.1 ± 987.69
Average daily dose (mg/day)62.45 ± 13.6276.72 ± 8.5869.55 ± 13.43
Dose modification during the second week (%)60.68.234.5


Write to the Help Desk